Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$28.96 USD
-1.04 (-3.47%)
Updated May 10, 2024 03:59 PM ET
After-Market: $28.95 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.38 |
EPS Last Quarter | 0.00 |
Last EPS Surprise | -100.00% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.64 |
Next Year | 1.95 |
EPS (TTM) | -0.29 |
P/E (F1) | 17.69 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 148.80M | 152.53M | 600.20M | 624.47M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 154.31M | 160.99M | 610.09M | 662.80M |
Low Estimate | 145.10M | 145.80M | 588.50M | 593.20M |
Year ago Sales | 135.56M | 153.88M | 607.52M | 600.20M |
Year over Year Growth Est. | 9.77% | -0.88% | -1.21% | 4.04% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.38 | 0.39 | 1.64 | 1.95 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.40 | 0.46 | 1.80 | 2.55 |
Low Estimate | 0.35 | 0.32 | 1.53 | 1.04 |
Year ago EPS | -0.02 | -0.29 | 0.02 | 1.64 |
Year over Year Growth Est. | 2,000.00% | 234.48% | 8,100.00% | 18.90% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.38 | 0.39 | 1.64 | 1.95 |
7 Days Ago | 0.38 | 0.39 | 1.64 | 1.95 |
30 Days Ago | 0.38 | 0.39 | 1.64 | 1.95 |
60 Days Ago | 0.38 | 0.39 | 1.64 | 1.95 |
90 Days Ago | 0.45 | 0.48 | 1.84 | 2.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.38 | 0.39 | 1.64 | 1.95 |
Zacks Consensus Estimate | 0.38 | 0.39 | 1.64 | 1.95 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.00 | 0.02 | -0.29 | -0.02 | NA |
Estimate | 0.39 | 0.41 | 0.13 | 0.23 | NA |
Difference | -0.39 | -0.39 | -0.42 | -0.25 | -0.36 |
Surprise | -100.00% | -95.12% | -323.08% | -108.70% | -156.73% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more